Ascendis Pharma (ASND1N) Q2 2024 Earnings Report
MX:ASND1N Q2 2024 EPS Results
- Actual EPS
- -MXN 40.07
- Consensus EPS
- -MXN 30.59
- Beat/Miss
- Missed by -MXN 9.48
- One Year Ago EPS
- -MXN 45.31
MX:ASND1N Q2 2024 Revenue Results
- Actual Revenue
- MXN 728.29M
- Expected Revenue
- MXN 1.74B
- Beat/Miss
- Missed by -MXN 1.01B
- YoY Revenue Growth
- -24.86%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 09/03/2024
- Time
- After Close
- Conference Call
- Tuesday, September 3, 2024
MX:ASND1N Upcoming Earnings
Ascendis Pharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ASND1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | 16.49- | -20.98 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | 31.4159.37 | -17.2 | 445.12% (+76.57) | |
| May 07, 2026 | 2026 (Q1) | 3.40204.54 | -33.15 | 717.09% (+237.69) | |
| Feb 11, 2026 | 2025 (Q4) | -1.68-11.54 | -13.43 | 14.06% (+1.89) | |
| Nov 12, 2025 | 2025 (Q3) | -5.12-20.98 | -36.08 | 41.86% (+15.10) | |
| Aug 07, 2025 | 2025 (Q2) | -26.98-17.20 | -40.07 | 57.07% (+22.87) | |
| May 01, 2025 | 2025 (Q1) | -30.78-33.15 | -48.25 | 31.30% (+15.10) | |
| Feb 12, 2025 | 2024 (Q4) | -20.64-13.43 | -32.31 | 58.44% (+18.88) | |
| Nov 14, 2024 | 2024 (Q3) | -32.83-36.08 | -56.43 | 36.06% (+20.35) | |
| Sep 03, 2024 | 2024 (Q2) | -30.59-40.07 | -45.31 | 11.57% (+5.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
